1.36
price down icon2.86%   -0.04
after-market アフターアワーズ: 1.37 0.01 +0.74%
loading
前日終値:
$1.40
開ける:
$1.38
24時間の取引高:
526.61K
Relative Volume:
0.81
時価総額:
$85.80M
収益:
$139.77M
当期純損益:
$-97.62M
株価収益率:
-0.8608
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
-9.93%
1か月 パフォーマンス:
-15.00%
6か月 パフォーマンス:
-62.12%
1年 パフォーマンス:
-67.92%
1日の値動き範囲:
Value
$1.30
$1.445
1週間の範囲:
Value
$1.30
$1.58
52週間の値動き範囲:
Value
$0.9897
$5.77

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1170)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
341
Name
Twitter
@macrogenics
Name
次回の収益日
2025-03-07
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

MGNX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MGNX
Macrogenics Inc
1.36 95.27M 139.77M -97.62M -61.71M -1.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
May 30, 2025

MacroGenics (NASDAQ:MGNX) Upgraded to Hold at Wall Street Zen - Defense World

May 30, 2025
pulisher
May 29, 2025

Levi & Korsinsky Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

May 29, 2025
pulisher
May 27, 2025

MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Lazard Asset Management LLC Purchases New Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 27, 2025
pulisher
May 27, 2025

Northern Trust Corp Has $1.76 Million Stock Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 27, 2025
pulisher
May 26, 2025

Millennium Management LLC Sells 671,179 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 26, 2025
pulisher
May 23, 2025

Q2 Earnings Forecast for MacroGenics Issued By B. Riley - Defense World

May 23, 2025
pulisher
May 22, 2025

MacroGenics Holds Annual Stockholders Meeting on May 21 - TipRanks

May 22, 2025
pulisher
May 22, 2025

B. Riley Issues Pessimistic Forecast for MacroGenics (NASDAQ:MGNX) Stock Price - Defense World

May 22, 2025
pulisher
May 22, 2025

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher - simplywall.st

May 21, 2025
pulisher
May 20, 2025

4 Analysts Assess Macrogenics: What You Need To Know - Benzinga

May 20, 2025
pulisher
May 20, 2025

Macrogenics (MGNX) Target Price Reduced by B. Riley Securities | MGNX Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

MacroGenics (MGNX) Sees Target Price Cut Amid Pipeline Focus | MGNX Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

B. Riley Cuts Price Target on MacroGenics to $3 From $5, Keeps Neutral Rating - marketscreener.com

May 20, 2025
pulisher
May 17, 2025

Stifel Nicolaus Cuts MacroGenics (NASDAQ:MGNX) Price Target to $5.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Stifel Financial Corp Decreases Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 17, 2025
pulisher
May 17, 2025

Leerink Partnrs Predicts Weaker Earnings for MacroGenics - Defense World

May 17, 2025
pulisher
May 16, 2025

Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech

May 16, 2025
pulisher
May 16, 2025

Earnings Release: Here's Why Analysts Cut Their MacroGenics, Inc. (NASDAQ:MGNX) Price Target To US$4.50 - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

MacroGenics Inc. Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Has $2.33 Million Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 15, 2025
pulisher
May 14, 2025

MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

MGNX: Barclays Lowers Price Target for Macrogenics | MGNX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Stifel cuts MacroGenics stock target to $5, maintains Hold rating By Investing.com - Investing.com Canada

May 14, 2025
pulisher
May 14, 2025

MacroGenics (MGNX) Exceeds Revenue Expectations with Strong Pipe - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Macrogenics Inc (MGNX) Q1 2025 Earnings: EPS Loss of $0.65 Beats - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Macrogenics (MGNX) Receives Updated Price Target from Stifel | M - GuruFocus

May 14, 2025
pulisher
May 14, 2025

MacroGenics (MGNX) Price Target Lowered by Stifel | MGNX Stock N - GuruFocus

May 14, 2025
pulisher
May 14, 2025

MacroGenics (MGNX) Price Target Reduced by Barclays | MGNX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

MacroGenics price target lowered to $3 from $8 at Barclays - TipRanks

May 14, 2025
pulisher
May 13, 2025

MacroGenics Inc earnings matched, revenue fell short of estimates By Investing.com - Investing.com India

May 13, 2025
pulisher
May 13, 2025

MacroGenics: Q1 Earnings Snapshot - Huron Daily Tribune

May 13, 2025
pulisher
May 13, 2025

MacroGenics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

MacroGenics Inc earnings matched, revenue fell short of estimates - Investing.com

May 13, 2025
pulisher
May 13, 2025

Macrogenics Inc (MGNX) Q1 2025 Earnings: EPS Loss of $0.65 Beats Estimate, Revenue Soars to $13.2 Million, Surpassing Expectations - GuruFocus

May 13, 2025
pulisher
May 13, 2025

MacroGenics reports Q1 EPS (65c), consensus (69c) - TipRanks

May 13, 2025
pulisher
May 13, 2025

Analysts Set MacroGenics, Inc. (NASDAQ:MGNX) Target Price at $7.43 - Defense World

May 13, 2025
pulisher
May 12, 2025

What To Expect From Macrogenics Inc (MGNX) Q1 2025 Earnings - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Wells Fargo & Company MN Increases Stock Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 12, 2025
pulisher
May 11, 2025

MGNX DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline - ACCESS Newswire

May 11, 2025
pulisher
May 11, 2025

Class Action Filed Against MacroGenics, Inc. (MGNX)September 24, 2024 Deadline to Join – Contact Levi & Korsinsky - ACCESS Newswire

May 11, 2025
pulisher
May 11, 2025

Barclays PLC Increases Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 11, 2025
pulisher
May 10, 2025

Levi & Korsinsky Announces an Investigation on Behalf of MacroGenics, Inc. (MGNX) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire

May 10, 2025

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):